SNPHY (Santen Pharmaceutical Co) Total Payout Ratio : 1.59 (As of Dec. 13, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Santen Pharmaceutical Co's current Total Payout Ratio is 1.59.

Santen Pharmaceutical Co Total Payout Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Total Payout Ratio Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Payout Ratio

Get a 7-Day Free Trial

0.48

1.23

0.44

-2.58

1.08

Santen Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Payout Ratio	Get a 7-Day Free Trial															0.55	1.50	0.72	1.71	1.53

Competitive Comparison of Santen Pharmaceutical Co's Total Payout Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santen Pharmaceutical Co's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Total Payout Ratio falls into.

Santen Pharmaceutical Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Santen Pharmaceutical Co's Total Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-113.217	+	0	+	-79.303)	/	178.236
	=	1.08

Santen Pharmaceutical Co's Total Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-86	+	0	+	-0.497)	/	56.641
	=	1.53

Santen Pharmaceutical Co Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

SNPHF:USA 4536:Japan SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.